SIGLEC1 and breast neoplasm: Comparing the proteome of SCS and MS CD169+ macrophages, also enable evaluation of our previous findings regarding tumor infiltrating CD169+ macrophages in primary breast tumors [24], indicating that these could be more similar to MS CD169+ macrophages than to SCS CD169+ macrophages.